MK-7622

MK-7622 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-7622, covering 2018-02-07 to 2018-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012) [Phase 2]

See pricing